The Impact of Eli Lilly's New DTC Platform on Rx Drug Sales and Patient Access: An Interview with Bill Roth, General Manager, Managing Partner, Blue Fin Group

In an interview with Nicholas Saraceno, Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses changes that will come with the pharma giant’s new platform.

Source link
#Impact #Eli #Lilly039s #DTC #Platform #Drug #Sales #Patient #Access #Interview #Bill #Roth #General #Manager #Managing #Partner #Blue #Fin #Group